par 164 (Benztropine 0.5 mg)
Pill imprint par 164 has been identified as Benztropine mesylate 0.5 mg.
Benztropine is used in the treatment of hyperhidrosis; extrapyramidal reaction; parkinson's disease and belongs to the drug class anticholinergic antiparkinson agents. FDA has not classified the drug for risk during pregnancy. Benztropine 0.5 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for par 164
- 0.5 mg
- 6.00 mm
- Prescription only
- Drug Class:
- Anticholinergic antiparkinson agents
- Pregnancy Category:
- N - Not classified
- CSA Schedule:
- N - Not a controlled drug
- Par Pharmaceutical Inc.
- National Drug Code (NDC):
|NDC Code||Manufacturer / Repackager|
|00182-1299||Goldline Laboratories Inc|
|63739-0033||McKesson Packaging Services|
|68115-0826||Dispensexpress Inc (repackager)|
Note: Inactive ingredients may vary.
More about benztropine
- Benztropine tablets
- Benztropine (Advanced Reading)
- Benztropine Injection (Advanced Reading)
- Other brands: Cogentin
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.